These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 30459764)

  • 1. Sepsis and Nosocomial Infection: Patient Characteristics, Mechanisms, and Modulation.
    Denstaedt SJ; Singer BH; Standiford TJ
    Front Immunol; 2018; 9():2446. PubMed ID: 30459764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innovative therapeutic strategies for restoring lymphocyte functions in septic patients.
    Turrel F; Guignant C; Venet F; Lepape A; Monneret G
    Inflamm Allergy Drug Targets; 2008 Sep; 7(3):181-6. PubMed ID: 18782025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathophysiological basis of surgery-linked sepsis].
    Vollmar B
    Chirurg; 2011 Mar; 82(3):199-207. PubMed ID: 21249327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reversing ICU-acquired immunosuppression: an innovative biomarker-guided therapeutic strategy for decreasing sepsis mortality and nosocomial infection rate].
    Monneret G; Lepape A; Venet F
    Pathol Biol (Paris); 2011 Dec; 59(6):329-33. PubMed ID: 21981928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential immunological mechanisms of sepsis.
    Zhang X; Zhang Y; Yuan S; Zhang J
    Front Immunol; 2024; 15():1434688. PubMed ID: 39040114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B and T lymphocyte attenuator expression on CD4+ T-cells associates with sepsis and subsequent infections in ICU patients.
    Shubin NJ; Monaghan SF; Heffernan DS; Chung CS; Ayala A
    Crit Care; 2013 Nov; 17(6):R276. PubMed ID: 24289156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Sepsis-Induced Immunosuppression.
    Venet F; Rimmelé T; Monneret G
    Crit Care Clin; 2018 Jan; 34(1):97-106. PubMed ID: 29149944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression.
    Patil NK; Bohannon JK; Sherwood ER
    Pharmacol Res; 2016 Sep; 111():688-702. PubMed ID: 27468649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dendritic cells in sepsis: an approach to post-infectious immunosuppression].
    Sirgo G; Claramonte R; Chánovas M; Esteban F; Forcadell I; Luna J; Masdeu G; Ramón Vázquez J; Artigas A
    Med Intensiva; 2010 Nov; 34(8):559-66. PubMed ID: 20034705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony.
    Monneret G; Venet F; Pachot A; Lepape A
    Mol Med; 2008; 14(1-2):64-78. PubMed ID: 18026569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The changing immune system in sepsis: is individualized immuno-modulatory therapy the answer?
    Boomer JS; Green JM; Hotchkiss RS
    Virulence; 2014 Jan; 5(1):45-56. PubMed ID: 24067565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment with 6-Gingerol Ameliorates Sepsis-Induced Immune Dysfunction by Regulating the Cytokine Balance and Reducing Lymphocyte Apoptosis.
    Ju SA; Nguyen QT; Nguyen TT; Suh JH; An WG; Callaway Z; Joe Y; Chung HT; Kim BS
    Oxid Med Cell Longev; 2021; 2021():5427153. PubMed ID: 35003518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of biomarkers of response to IFNg during endotoxin tolerance: application to septic shock.
    Allantaz-Frager F; Turrel-Davin F; Venet F; Monnin C; De Saint Jean A; Barbalat V; Cerrato E; Pachot A; Lepape A; Monneret G
    PLoS One; 2013; 8(7):e68218. PubMed ID: 23874546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers of sepsis.
    Faix JD
    Crit Rev Clin Lab Sci; 2013; 50(1):23-36. PubMed ID: 23480440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunopathogenesis of abdominal sepsis.
    Weber GF; Swirski FK
    Langenbecks Arch Surg; 2014 Jan; 399(1):1-9. PubMed ID: 24121723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and cellular aspects of sepsis-induced immunosuppression.
    Wang TS; Deng JC
    J Mol Med (Berl); 2008 May; 86(5):495-506. PubMed ID: 18259721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal trends of circulating nitric oxide and pro-inflammatory cytokine responses ex vivo in intra-abdominal sepsis: results from a cohort study.
    Ojeda Ojeda M; Larrondo Muguercia H; Magdariaga Figuerola A; Sánchez Valdivia A; Rodríguez Alonso I; Valenzuela Silva C; García Iglesias E; Domínguez Alonso E; Buurman WA; Araña Rosaínz Mde J
    Inflamm Res; 2011 Mar; 60(3):289-97. PubMed ID: 20976525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy for the adjunctive treatment of sepsis: from immunosuppression to immunostimulation. Time for a paradigm change?
    Leentjens J; Kox M; van der Hoeven JG; Netea MG; Pickkers P
    Am J Respir Crit Care Med; 2013 Jun; 187(12):1287-93. PubMed ID: 23590272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Unbalanced Inflammatory Cytokine Response Is Not Associated With Mortality Following Sepsis: A Prospective Cohort Study.
    Frencken JF; van Vught LA; Peelen LM; Ong DSY; Klein Klouwenberg PMC; Horn J; Bonten MJM; van der Poll T; Cremer OL;
    Crit Care Med; 2017 May; 45(5):e493-e499. PubMed ID: 28257334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory mechanisms of sepsis.
    Shubin NJ; Monaghan SF; Ayala A
    Contrib Microbiol; 2011; 17():108-124. PubMed ID: 21659749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.